Chief, Microbiology & Immunology Division, Department of Pathology at the University of Utah.
Only show posts containing:
Hide posts containing:
Spinout NanoKar Therapeutics is developing a way to fine-tune existing CAR-T treatments so the cells can last longer and work more effectively.